BG
FURX

BlackRock Group’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

BlackRock Group’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-311
Closed -$33K – 2947
2014
Q2 		$33K Sell
311
-2,219
-88% -$218K ﹤0.01% 2740
2014
Q1 		$219K Buy
+2,530
New +$195K ﹤0.01% 2455

BlackRock Group's FURX Position: Q3 2014 in Review

BlackRock Group sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 311 shares — an estimated $33K sold.

BlackRock Group first reported a position in FURX in Q1 2014 and held it in 2 quarters. The position peaked at $219K in Q1 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • BlackRock Group reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • BlackRock Group sold 311 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $33K.
  • BlackRock Group first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 2 quarters.
  • BlackRock Group's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $219K in Q1 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on BlackRock Group's 13F filing for Q3 2014, filed 29 Oct 2014.